Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

ClinicalTrials.gov ID: NCT00672620

Public ClinicalTrials.gov record NCT00672620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Referenced, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the efficacy and safety of vortioxetine, once daily (QD), in adults with major depressive disorder.

Study identification

NCT ID
NCT00672620
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
611 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2008 (Type not available)
Primary completion
Nov 2008 (Actual)
Completion
Dec 2008 (Actual)
Last update posted
Dec 18, 2013

2008

United States locations

U.S. sites
38
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
Not listed Beverly Hills California — —
Not listed Irvine California — —
Not listed Santa Ana California — —
Not listed Torrance California — —
Not listed Upland California — —
Not listed Bradenton Florida — —
Not listed Coral Springs Florida — —
Not listed Fort Walton Beach Florida — —
Not listed Gainesville Florida — —
Not listed Jacksonville Florida — —
Not listed Maitland Florida — —
Not listed Orlando Florida — —
Not listed South Miami Florida — —
Not listed West Palm Beach Florida — —
Not listed Atlanta Georgia — —
Not listed Smyrna Georgia — —
Not listed Chicago Illinois — —
Not listed Libertyville Illinois — —
Not listed Oak Brook Illinois — —
Not listed Prairie Village Kansas — —
Not listed Owensboro Kentucky — —
Not listed Baltimore Maryland — —
Not listed Pittsfield Massachusetts — —
Not listed Worcester Massachusetts — —
Not listed Flowood Mississippi — —
Not listed New York New York — —
Not listed Olean New York — —
Not listed Beachwood Ohio — —
Not listed Toledo Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Allenport Pennsylvania — —
Not listed Lancaster Pennsylvania — —
Not listed Memphis Tennessee — —
Not listed Austin Texas — —
Not listed San Antonio Texas — —
Not listed Salt Lake City Utah — —
Not listed Seattle Washington — —
Not listed Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00672620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2013 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00672620 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →